Skip to main content
PVCT logo

PVCT · Provectus Biopharmaceuticals, Inc.

Track PVCT — free
$0.06 0.00 (-2.67%) At close · Aug 28
Market Cap
$24.38M
Shares
420.28M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Edward Pershing $315,000
Dominic Rodrigues $315,000
Eric Wachter $240,000
Heather Raines $200,000
Fiscal 2024
Executive Total
Edward Pershing $2,147,650
Dominic Rodrigues $1,464,967
Heather Raines $444,837
Eric Wachter $399,752
Bruce Horowitz $63,600
Fiscal 2023
Executive Total
Bruce Horowitz $254,400
Eric Wachter $240,000
Heather Raines $125,000
Dominic Rodrigues
Edward Pershing
Fiscal 2022
Executive Total
Bruce Horowitz $329,400
Eric Wachter $254,188
Heather Raines $125,000
Fiscal 2021
Executive Total
Bruce Horowitz $244,600
Eric Wachter $170,804
Heather Raines $83,333
Fiscal 2020
Executive Total
Bruce Horowitz $444,200
Eric Wachter $230,861
Heather Raines $118,747
Fiscal 2019
Executive Total
Eric Wachter $478,045
Bruce Horowitz $352,200
Timothy C. Scott $160,017
Heather Raines $130,805
Fiscal 2018
Executive Total
Timothy C. Scott $328,473
Eric Wachter $328,360
Bruce Horowitz $265,000
Heather Raines $101,323

Executive changes

Person Change Filed
Ed Pershing Appointed 2024-04-16
Dominic Rodrigues Appointed 2024-03-26
Bruce Horowitz Resigned 2024-03-26
Bruce Horowitz Resigned 2024-03-26
Webster Bailey Appointed 2020-07-16
Jan Koe Resigned 2020-07-16
Key facts CIK 315545 CUSIP 74373P108 13F (30d) 1 filings 1 filers Visit website